HQY

HQY

USD

HealthEquity Inc. Common Stock

$103.250-1.260 (-1.206%)

Preço em tempo real

Healthcare
Health Information Services
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$104.510

Máximo

$104.560

Mínimo

$103.250

Volume

0.85M

Fundamentos da empresa

Capitalização de mercado

8.9B

Setor

Health Information Services

País

United States

Estatísticas de negociação

Volume médio

1.26M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $65.01Atual $103.250Máximo $116.65

Notícias relacionadas

Analyst Upgrades

Barrington Research Maintains Outperform on HealthEquity, Raises Price Target to $125

Barrington Research analyst Alexander Paris maintains HealthEquity with a Outperform and raises the price target from $112 to $125.

Ver mais
Barrington Research Maintains Outperform on HealthEquity, Raises Price Target to $125
Analyst Upgrades

Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $115

Deutsche Bank analyst George Hill maintains HealthEquity with a Buy and raises the price target from $98 to $115.

Ver mais
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $115
Analyst Upgrades

Goldman Sachs Maintains Neutral on HealthEquity, Raises Price Target to $104

Goldman Sachs analyst David Roman maintains HealthEquity with a Neutral and raises the price target from $94 to $104.

Ver mais
Goldman Sachs Maintains Neutral on HealthEquity, Raises Price Target to $104
Analyst Upgrades

RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $117

RBC Capital analyst Daniel Perlin maintains HealthEquity with a Outperform and raises the price target from $112 to $117.

Ver mais
RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $117
Analyst Upgrades

B of A Securities Maintains Buy on HealthEquity, Raises Price Target to $125

B of A Securities analyst Allen Lutz maintains HealthEquity with a Buy and raises the price target from $110 to $125.

Ver mais
B of A Securities Maintains Buy on HealthEquity, Raises Price Target to $125
Analyst Upgrades

JMP Securities Maintains Market Outperform on HealthEquity, Raises Price Target to $117

JMP Securities analyst Constantine Davides maintains HealthEquity with a Market Outperform and raises the price target from $110 to $117.

GlobeNewswire

HealthEquity Reports First Quarter Ended April 30, 2025 Financial Results

Highlights of the first quarter include: Revenue of $330.8 million, an increase of 15% compared to $287.6 million in Q1 FY25.Net income of $53.9 million, an increase of 87% compared to $28.8 million in Q1 FY25, with

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.